<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR11">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hayden</surname>
    <given-names>F. G.</given-names>
   </name>
   <name>
    <surname>Turner</surname>
    <given-names>R. B.</given-names>
   </name>
   <name>
    <surname>Gwaltney</surname>
    <given-names>J. M.</given-names>
   </name>
   <name>
    <surname>Chi-Burris</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Gersten</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hsyu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Patick</surname>
    <given-names>A. K.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>G. J.</given-names>
   </name>
   <name>
    <surname>Zalman</surname>
    <given-names>L. S.</given-names>
   </name>
  </person-group>
  <article-title>Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers</article-title>
  <source>Antimicrobial Agents and Chemotherapy</source>
  <year>2003</year>
  <volume>47</volume>
  <issue>12</issue>
  <fpage>3907</fpage>
  <lpage>3916</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.47.12.3907-3916.2003</pub-id>
  <pub-id pub-id-type="pmid">14638501</pub-id>
 </element-citation>
</ref>
